Abstract:Background and objective: The effectiveness of radiofrequency ablation (RFA) in improving long-term survival outcomes for patients with a solitary hepatocellular carcinoma (HCC) measuring 5 cm or less remains uncertain. This study was designed to elucidate the impact of RFA therapy on the survival outcomes of these patients and to construct a prognostic model for patients following RFA. Methods: This study was performed using the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2017, focusing on patients diagnosed with a solitary HCC lesion ≤5 cm in size. We compared the overall survival (OS) and cancer-specific survival (CSS) rates of these patients with those of patients who received hepatectomy, radiotherapy, or chemotherapy or who were part of a blank control group. To enhance the reliability of our findings, we employed stabilized inverse probability treatment weighting (sIPTW) and stratified analyses. Additionally, we conducted a Cox regression analysis to identify prognostic factors. XGBoost models were developed to predict 1-, 3-, and 5-year CSS. The XGBoost models were evaluated via receiver operating characteristic (ROC) curves, calibration plots, decision curve analysis (DCA) curves and so on. Results: Regardless of whether the data were unadjusted or adjusted for the use of sIPTWs, the 5-year OS (46.7%) and CSS (58.9%) rates were greater in the RFA group than in the radiotherapy (27.1%/35.8%), chemotherapy (32.9%/43.7%), and blank control (18.6%/30.7%) groups, but these rates were lower than those in the hepatectomy group (69.4%/78.9%). Stratified analysis based on age and cirrhosis status revealed that RFA and hepatectomy yielded similar OS and CSS outcomes for patients with cirrhosis aged over 65 years. Age, race, marital status, grade, cirrhosis status, tumor size, and AFP level were selected to construct the XGBoost models based on the training cohort. The areas under the curve (AUCs) for 1, 3, and 5 years in the validation cohort were 0.88, 0.81, and 0.79, respectively. Calibration plots further demonstrated the consistency between the predicted and actual values in both the training and validation cohorts. Conclusion: RFA can improve the survival of patients diagnosed with a solitary HCC lesion ≤5 cm. In certain clinical scenarios, RFA achieves survival outcomes comparable to those of hepatectomy. The XGBoost models developed in this study performed admirably in predicting the CSS of patients with solitary HCC tumors smaller than 5 cm following RFA.

Gross Classification of Solitary Small Hepatocellular Carcinoma on Preoperative Computed Tomography: Prognostic Significance after Radiofrequency Ablation.

Role of preoperative morphologic classification in solitary small hepatocellular carcinoma treated by RFA

Surgical Resection Plus Radiofrequency Ablation Versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Treatment Protocols For Small Hepatocellular Carcinoma (<= 3 Cm): Rfa Or Resection?

Radiofrequency Ablation of Hepatocellular Carcinoma: Long-Term Outcome and Prognostic Factors

[Survival and Prognostic Analysis of Radiofrequency Ablation of Hepatocellular Carcinoma].

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

Overall Survival and Disease-Free Survival of Radiofrequency Ablation of Hepatocellular Carcinoma

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation

Retrospective Analysis of Radiofrequency Ablation in Patients with Small Solitary Hepatocellular Carcinoma: Survival Outcomes and Development of a Machine Learning Prognostic Model

The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma after Hepatectomy.

[Long Term (5 Years) Outcome of Radiofrequency Ablation for Hepatocellular Carcinoma in 256 Cases].

Prospective Comparative Study of Cool-Tip Radiofrequency Ablation and Surgical Resection for Hepatocellular Carcinoma

Long-term Outcomes and Prognostic Analysis of Radiofrequency Ablation for Small Hepatocellular Carcinoma: 10-Year Follow-Up in Chinese Patients

Analysis of risk factors for local tumor progression after radiofrequency ablation of hepatocellular carcinoma

Clinical prognostic factors analysis of radiofrequency ablation on 194 cases of primary hepatocellular carcinoma

[A Tailored Approach to Radiofrequency Ablation of Hepatocellular Carcinoma and Its Outcome].

Radiofrequency Ablation for Hepatocellular Carcinoma: Our Perspectives on Patient Selection and Curative Results

Therapeutic effect of radiofrequency ablation in unsuitable operative small hepatocellular carcinoma

Laparoscopic Ultrasound Graded Radiofrequency Ablation for Hepatocellular Carcinoma:Preliminary Experience

Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation